Given that TTBK1 has been considered a plausible therapeutic target for the treatment of Alzheimer’s disease (AD)47,55–57, its direct involvement in primary cilia regulation may significantly hamper these efforts in AD targeting. Here, TTBK1 is linked to early-onset autosomal dominant Alzheimer disease.